November

A top-ranked business school has taken a look at the wish list of aspiring entrepreneurs. What tops that list might surprise you.

If you guessed that the top life sciences markets are on the east and west coasts, you'd be right. However, several parts of the Midwest are now considered emerging markets. Read more to learn the locations of the top 10 life sciences markets.

Nanotechnology firms will benefit from $3 million in grants from a Pennsylvania organization that wants to encourage innovation. Read more about this program for businesses and colleges.

Medical device startups should take notice of the legal case that sent a medical device maker's corporate officers to prison because of clinical trial missteps. Read more about the case.

Successful global entrepreneurs actually thrive during difficult times and find opportunities, according to a new Ernst & Young study. Read more about their secrets to success.

Some entrepreneurial incubators are better than others. For a good role model, check out the University of Michigan.

In the healthcare business landscape, there's plenty of healthcare investing happening. However, there are still medical problems that could benefit from more investment. Read more about them.

In Part Two of our look at early-stage entrepreneurial funding, we examine the pros and cons of the two primary startup funding mechanisms: venture capital and angel funding.

As year-end approaches and entrepreneurs regroup to figure out financing options for 2012, it's a good time to take a look at the two major sources of new business funding -- angel investing versus venture capital.

The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.